Hikma Pharmaceuticals HKMPF Stock
Hikma Pharmaceuticals Price Chart
Hikma Pharmaceuticals HKMPF Financial and Trading Overview
| Hikma Pharmaceuticals stock price | 19.29 USD |
| Previous Close | 19.29 USD |
| Open | 19.07 USD |
| Bid | 19.05 USD x 10000 |
| Ask | 20.12 USD x 10000 |
| Day's Range | 19.07 - 19.07 USD |
| 52 Week Range | 16.34 - 27.96 USD |
| Volume | 40 USD |
| Avg. Volume | 141 USD |
| Market Cap | 4.03B USD |
| Beta (5Y Monthly) | 0.653 |
| PE Ratio (TTM) | 10.535912 |
| EPS (TTM) | 1.81 USD |
| Forward Dividend & Yield | 0.84 (4.34%) |
| Ex-Dividend Date | March 19, 2026 |
| 1y Target Est | N/A |
HKMPF Valuation Measures
| Enterprise Value | 5.62B USD |
| Trailing P/E | 10.535912 |
| Forward P/E | 8.255411 |
| PEG Ratio (5 yr expected) | 1.71 |
| Price/Sales (ttm) | 1.204566 |
| Price/Book (mrq) | 1.618708 |
| Enterprise Value/Revenue | 1.678 |
| Enterprise Value/EBITDA | 6.674 |
Trading Information
Hikma Pharmaceuticals Stock Price History
| Beta (5Y Monthly) | 0.653 |
| 52-Week Change | -30.43% |
| S&P500 52-Week Change | 24.48% |
| 52 Week High | 27.96 USD |
| 52 Week Low | 16.34 USD |
| 50-Day Moving Average | 18.92 USD |
| 200-Day Moving Average | 20.42 USD |
HKMPF Share Statistics
| Avg. Volume (3 month) | 141 USD |
| Avg. Daily Volume (10-Days) | 0 USD |
| Shares Outstanding | 211.54M |
| Float | 149.8M |
| Short Ratio | N/A |
| % Held by Insiders | 32.24% |
| % Held by Institutions | 46.68% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0.84 |
| Trailing Annual Dividend Yield | 4.35% |
| 5 Year Average Dividend Yield | 283.00% |
| Payout Ratio | 0.4641 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2025 |
| Most Recent Quarter (mrq) | December 31, 2025 |
| Next Fiscal Year End | December 31, 2026 |
Profitability
| Profit Margin | 12.00% |
| Operating Margin (ttm) | 16.20% |
| Gross Margin | 43.50% |
| EBITDA Margin | 25.14% |
Management Effectiveness
| Return on Assets (ttm) | 7.49% |
| Return on Equity (ttm) | 16.52% |
Income Statement
| Revenue (ttm) | 3.35B USD |
| Revenue Per Share (ttm) | 15.18 USD |
| Quarterly Revenue Growth (yoy) | 8.50% |
| Gross Profit (ttm) | 1.46B USD |
| EBITDA | 842M USD |
| Net Income Avi to Common (ttm) | 402M USD |
| Diluted EPS (ttm) | 1.81 |
| Quarterly Earnings Growth (yoy) | 23.30% |
Balance Sheet
| Total Cash (mrq) | 243M USD |
| Total Cash Per Share (mrq) | 1.1 USD |
| Total Debt (mrq) | 1.6B USD |
| Total Debt/Equity (mrq) | 61.55 USD |
| Current Ratio (mrq) | 1.819 |
| Book Value Per Share (mrq) | 11.781 |
Cash Flow Statement
| Operating Cash Flow (ttm) | 436M USD |
| Levered Free Cash Flow (ttm) | -66125000 USD |
Profile of Hikma Pharmaceuticals
| Country | United States |
| State | N/A |
| City | London |
| Address | 10 Portman Square |
| ZIP | W1H 6AZ |
| Phone | 44 20 7399 2760 |
| Website | https://www.hikma.com |
| Industry | Drug Manufacturers - Specialty & Generic |
| Sector(s) | Healthcare |
| Full Time Employees | 9400 |
Hikma Pharmaceuticals PLC develops, manufactures, markets, and sells a range of generic, specialty, and branded pharmaceutical products. The company operates through three segments: Injectables, Hikma Rx, and Branded. The Injectables segment provides generic and specialty injectable products primarily for use in hospitals. The Branded segment offers branded generics and in-licensed products to retail and hospital markets. The Hikma Rx segment offers oral, respiratory, and other generic and specialty products for the retail market. It provides its products in various therapeutic areas, including respiratory, oncology, and pain management. The company also offers its products in solid, semi-solid, liquid, and injectable dosage forms. It operates in the United Kingdom, Europe, North America, the Middle East, North Africa, and internationally. Hikma Pharmaceuticals PLC was founded in 1978 and is headquartered in London, United Kingdom.
Q&A For Hikma Pharmaceuticals Stock
What is a current HKMPF stock price?
Hikma Pharmaceuticals HKMPF stock price today per share is 19.29 USD.
How to purchase Hikma Pharmaceuticals stock?
You can buy HKMPF shares on the OTC Markets OTCPK exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Hikma Pharmaceuticals?
The stock symbol or ticker of Hikma Pharmaceuticals is HKMPF.
Which industry does the Hikma Pharmaceuticals company belong to?
The Hikma Pharmaceuticals industry is Drug Manufacturers - Specialty & Generic.
How many shares does Hikma Pharmaceuticals have in circulation?
The max supply of Hikma Pharmaceuticals shares is 210.48M.
What is Hikma Pharmaceuticals Price to Earnings Ratio (PE Ratio)?
Hikma Pharmaceuticals PE Ratio is 10.65745900 now.
What was Hikma Pharmaceuticals earnings per share over the trailing 12 months (TTM)?
Hikma Pharmaceuticals EPS is 1.81 USD over the trailing 12 months.
Which sector does the Hikma Pharmaceuticals company belong to?
The Hikma Pharmaceuticals sector is Healthcare.